TD Cowen Has Lowered Expectations for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Acadia Healthcare (NASDAQ:ACHC) had its price objective lowered by TD Cowen from $70.00 to $66.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. TD Cowen’s target price indicates a potential upside of 46.28% from the company’s current price.

Other equities research analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp upgraded shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a research note on Tuesday. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday. Finally, Barclays dropped their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Trading Down 0.0 %

Shares of ACHC stock opened at $45.12 on Tuesday. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a 50-day simple moving average of $40.43 and a two-hundred day simple moving average of $58.28. The company has a market capitalization of $4.19 billion, a price-to-earnings ratio of 14.79, a PEG ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period in the prior year, the firm posted $0.91 EPS. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. Research analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of institutional investors have recently modified their holdings of the business. State Street Corp lifted its stake in Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after purchasing an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares in the last quarter. LMR Partners LLP purchased a new stake in Acadia Healthcare in the 3rd quarter worth approximately $1,616,000. Principal Financial Group Inc. lifted its stake in Acadia Healthcare by 2.1% in the 3rd quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after purchasing an additional 13,368 shares in the last quarter. Finally, Texas Permanent School Fund Corp increased its holdings in shares of Acadia Healthcare by 11.3% in the 2nd quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company’s stock worth $6,067,000 after buying an additional 9,115 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.